• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Surrozen Reports Inducement Grant Under Nasdaq Listing Rule

    GLOBENEWSWIRE

    Surrozen Reports 2025 Financial Results And Business Update

    GLOBENEWSWIRE

    Surrozen To Present At Upcoming Healthcare Investor Conference

    GLOBENEWSWIRE

    Surrozen Grants Inducement Under Nasdaq LR 5635(C)(4)

    GLOBENEWSWIRE

    Surrozen To Present At Upcoming Healthcare Investor Conference

    GLOBENEWSWIRE

    Surrozen To Present At Upcoming Healthcare Investor Conferences

    GLOBENEWSWIRE

    Surrozen Grants Inducement Under Nasdaq LR 5635(C)(4)

    GLOBENEWSWIRE

    Surrozen Reports Q3 2025 Financial Results & Business Update

    GLOBENEWSWIRE

    Surrozen To Present at Upcoming Healthcare Investor Conference

    GLOBENEWSWIRE

    Surrozen Reports Inducement Grants Under Nasdaq LR 5635(c)(4)

    GLOBENEWSWIRE

    Surrozen to Present at Upcoming Healthcare Investor Conference

    GLOBENEWSWIRE

    Surrozen to Present at Upcoming Healthcare Investor Conference

    GLOBENEWSWIRE

    Surrozen to Present at Upcoming Healthcare Investor Conference

    GLOBENEWSWIRE

    Surrozen Granted Patent from the Wnt Pathway

    GLOBENEWSWIRE

    Surrozen Reports Q1 2025 Financial Results and Business Update

    GLOBENEWSWIRE

    Surrozen Raises $175M for Wnt Mimetic Therapeutics in Eye Disease

    GLOBENEWSWIRE

    Surrozen & TCGFB Announce Collaboration for IPF TGF-? Antibodies

    GLOBENEWSWIRE

    The Column Group biotech taps Surrozen to target lung fibrosis

    FIERCE BIOTECH

    Surrozen: Phase 1b Dosing For SZN-043 In Severe Alcoholic Hepatitis

    GLOBENEWSWIRE

    Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.